How Cost Affects the Treatment Choice for Irritable Bowel Syndrome with Diarrhea Patients: A Cost-Effectiveness Analysis of Tricyclic Agents and Rifaximin

2017 ◽  
Vol 152 (5) ◽  
pp. S118
Author(s):  
Eric D. Shah ◽  
Elizabeth Andraska ◽  
Jonathan Li ◽  
Sai Zhang ◽  
William D. Chey
Keyword(s):  
Irritable Bowel Syndrome ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Treatment Choice ◽  
Effectiveness Analysis ◽  
Irritable Bowel

scholarly journals Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: A cost-effectiveness analysis☆

2004 ◽  
Vol 126 (7) ◽  
pp. 1721-1732 ◽  
Author(s):  
Brennan M.R. Spiegel ◽  
Vincent P. DeRosa ◽  
Ian M. Gralnek ◽  
Victor Wang ◽  
Gareth S. Dulai
Keyword(s):  
Irritable Bowel Syndrome ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Celiac Sprue ◽  
Effectiveness Analysis ◽  
Irritable Bowel

Cost-Effectiveness Analysis Methods

2002 ◽  
Author(s):  
Eugene Laska ◽  
Morris Meisner ◽  
Carole Siegel ◽  
Joseph Wanderling
Keyword(s):  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Analysis Methods
Sign in / Sign up

Export Citation Format

Share Document